Literature DB >> 12005439

Structural milestones in the reaction pathway of an amide hydrolase: substrate, acyl, and product complexes of cephalothin with AmpC beta-lactamase.

Beth M Beadle1, Indi Trehan, Pamela J Focia, Brian K Shoichet.   

Abstract

Beta-lactamases hydrolyze beta-lactam antibiotics and are the leading cause of bacterial resistance to these drugs. Although beta-lactamases have been extensively studied, structures of the substrate-enzyme and product-enzyme complexes have proven elusive. Here, the structure of a mutant AmpC in complex with the beta-lactam cephalothin in its substrate and product forms was determined by X-ray crystallography to 1.53 A resolution. The acyl-enzyme intermediate between AmpC and cephalothin was determined to 2.06 A resolution. The ligand undergoes a dramatic conformational change as the reaction progresses, with the characteristic six-membered dihydrothiazine ring of cephalothin rotating by 109 degrees. These structures correspond to all three intermediates along the reaction path and provide insight into substrate recognition, catalysis, and product expulsion.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12005439     DOI: 10.1016/s0969-2126(02)00725-6

Source DB:  PubMed          Journal:  Structure        ISSN: 0969-2126            Impact factor:   5.006


  48 in total

1.  Identification of residues critical for catalysis in a class C beta-lactamase by combinatorial scanning mutagenesis.

Authors:  Shalom D Goldberg; William Iannuccilli; Tuan Nguyen; Jingyue Ju; Virginia W Cornish
Journal:  Protein Sci       Date:  2003-08       Impact factor: 6.725

2.  Dynamical aspects of TEM-1 beta-lactamase probed by molecular dynamics.

Authors:  Danilo Roccatano; Gianluca Sbardella; Massimiliano Aschi; Gianfranco Amicosante; Cecilia Bossa; Alfredo Di Nola; Fernando Mazza
Journal:  J Comput Aided Mol Des       Date:  2005-05       Impact factor: 3.686

3.  Saturation mutagenesis of Asn152 reveals a substrate selectivity switch in P99 cephalosporinase.

Authors:  Scott T Lefurgy; René M de Jong; Virginia W Cornish
Journal:  Protein Sci       Date:  2007-12       Impact factor: 6.725

4.  Avibactam and class C β-lactamases: mechanism of inhibition, conservation of the binding pocket, and implications for resistance.

Authors:  S D Lahiri; M R Johnstone; P L Ross; R E McLaughlin; N B Olivier; R A Alm
Journal:  Antimicrob Agents Chemother       Date:  2014-07-14       Impact factor: 5.191

5.  Influence of substrates and inhibitors on the structure of Klebsiella pneumoniae carbapenemase-2.

Authors:  Ben A Shurina; Richard C Page
Journal:  Exp Biol Med (Maywood)       Date:  2019-06-04

6.  Site-saturation mutagenesis of position V117 in OXA-1 β-lactamase: effect of side chain polarity on enzyme carboxylation and substrate turnover.

Authors:  Jennifer S Buchman; Kyle D Schneider; Aaron R Lloyd; Stephanie L Pavlish; David A Leonard
Journal:  Biochemistry       Date:  2012-03-28       Impact factor: 3.162

7.  The role of the β5-α11 loop in the active-site dynamics of acylated penicillin-binding protein A from Mycobacterium tuberculosis.

Authors:  Alena Fedarovich; Robert A Nicholas; Christopher Davies
Journal:  J Mol Biol       Date:  2012-02-23       Impact factor: 5.469

8.  Engineering a model protein cavity to catalyze the Kemp elimination.

Authors:  Matthew Merski; Brian K Shoichet
Journal:  Proc Natl Acad Sci U S A       Date:  2012-09-17       Impact factor: 11.205

9.  Structural insight into potent broad-spectrum inhibition with reversible recyclization mechanism: avibactam in complex with CTX-M-15 and Pseudomonas aeruginosa AmpC β-lactamases.

Authors:  Sushmita D Lahiri; Stefano Mangani; Thomas Durand-Reville; Manuela Benvenuti; Filomena De Luca; Gautam Sanyal; Jean-Denis Docquier
Journal:  Antimicrob Agents Chemother       Date:  2013-02-25       Impact factor: 5.191

10.  Structure-based optimization of cephalothin-analogue boronic acids as beta-lactamase inhibitors.

Authors:  Stefania Morandi; Federica Morandi; Emilia Caselli; Brian K Shoichet; Fabio Prati
Journal:  Bioorg Med Chem       Date:  2007-11-07       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.